Origin Asset Management LLP Vertex Pharmaceuticals Inc Transaction History

Origin Asset Management LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $724,570 - $844,585	-3,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $153,390 - $181,860	600 Added 20.69%	3,500 $952,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $653,892 - $857,820	2,900 New	2,900 $842,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Origin Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Origin Asset Management LLP with notifications on news.